SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-23-000098
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:17
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20230930.htm   iXBRL 10-Q 1467050
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112023-09.htm EX-31.1 9848
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122023-09.htm EX-31.2 9857
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212023-09.htm EX-32.1 7356
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222023-09.htm EX-32.2 7424
11 GRAPHIC cdtx-20230930_g1.jpg GRAPHIC 23028
12 GRAPHIC cdtx-20230930_g10.jpg GRAPHIC 110340
13 GRAPHIC cdtx-20230930_g2.jpg GRAPHIC 265744
14 GRAPHIC cdtx-20230930_g3.jpg GRAPHIC 40726
15 GRAPHIC cdtx-20230930_g4.jpg GRAPHIC 33311
16 GRAPHIC cdtx-20230930_g5.jpg GRAPHIC 78600
17 GRAPHIC cdtx-20230930_g6.jpg GRAPHIC 60994
18 GRAPHIC cdtx-20230930_g7.jpg GRAPHIC 80495
19 GRAPHIC cdtx-20230930_g8.jpg GRAPHIC 42486
20 GRAPHIC cdtx-20230930_g9.jpg GRAPHIC 131758
  Complete submission text file 0001610618-23-000098.txt   8865250

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20230930.xsd EX-101.SCH 41799
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20230930_cal.xml EX-101.CAL 59704
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20230930_def.xml EX-101.DEF 225524
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20230930_lab.xml EX-101.LAB 556883
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20230930_pre.xml EX-101.PRE 359149
66 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20230930_htm.xml XML 912324
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 231372169
SIC: 2836 Biological Products, (No Diagnostic Substances)